Molecules 2020, 25, 2822
13 of 17
1507 cm−1; HRMS calcd for (C14H11N5S + H+): 282.0813; found: 282.0818; Anal. Calcd for C14H11N5S:
C, 59.77; H, 3.94; N, 24.89. Found: C, 59.83; H, 3.97; N, 24.93.
2-(4-Aminophenylazo)-5-(4-methoxyphenyl)-1,3,4-thiadiazole (4b). The product was obtained as a
1
brown reddish solid (2.47 g, 53%); mp 269–270 ◦C; Rf (CHCl3/EtOAc, 5:1 v/v) 0.16. H-NMR (400 MHz,
DMSO-d6):
J = 8.8 Hz, 5-Ar: H-30, H-50), 7.75 (d, 2H, J = 8.8 Hz, 2-Ar: H-2, H-6), 7.98 (d, 2H, J = 8.8 Hz, 5-Ar: H-20,
H-60); 13C-NMR (100 MHz, DMSO-d6):
55.5, 114.1, 114.8, 122.6, 127.6, 129.2, 142.3, 156.3, 161.8, 165.6,
179.5. IR (ATR)
: 3422, 3333, 1651, 1508 cm−1; HRMS calcd for (C15H13N5SO + H+): 312.0919; found:
δ 3.86 (s, 3H, OCH3), 6.74 (d, 2H, J = 8.8 Hz, 2-Ar: H-3, H-5), 7.06 (s, 2H, NH2), 7.11 (d, 2H,
δ
ν
312.0912; Anal. Calcd for C15H13N5SO: C, 57.86; H, 4.21; N, 22.49. Found: C, 57.73; H, 4.24; N, 22.43.
2-(4-Aminophenylazo)-5-(4-nitrophenyl)-1,3,4-thiadiazole (4c). The product was obtained as a dark
brown solid (3.42 g, 70%); mp 176–178 ◦C (178–179 ◦C [24]); Rf (CHCl3/EtOAc, 5:1 v/v) 0.23. IR (ATR)
ν:
3403, 1637, 1513 cm−1; Anal. Calcd for C14H10N6O2S: C, 51.53; H, 3.09; N, 25.75. Found: C, 51.47; H,
3.05; N, 25.77.
2-(4-Aminophenylazo)-5-(4-bromophenyl)-1,3,4-thiadiazole (4d). The product was obtained as a dark
1
violet solid (3.67 g, 68%); mp 261–263 ◦C; Rf (CHCl3/EtOAc, 3:1 v/v) 0.23. H-NMR (400 MHz DMSO-d6):
δ
6.75 (d, 2H, J = 9.2 Hz, 2-Ar: H-3, H-5), 7.18 (s, 2H, NH2), 7.75–7.78 (m, 4H, 2-Ar, 5-Ar: H-2, H-6,
H-30, H-50), 7.97 (d, 2H, J = 8.8 Hz, 5-Ar: H-20, H-60); 13C-NMR (100 MHz, DMSO-d6):
114.2, 124.9,
: 3321, 1636, 1507 cm−1; HRMS calcd for
δ
129.2, 129.3, 130.4, 132.4, 142.3, 156.7, 164.6, 180.5. IR (ATR)
(C14H10N5SBr+H+): 359.9919; found: 359.9914; Anal. Calcd for C14H10N5SBr: C, 46.68; H, 2.80; N,
ν
19.44. Found: C, 46.81; H, 2.79; N, 19.49.
2-(4-Aminophenylazo)-5-(4-t-butylphenyl)-1,3,4-thiadiazole (4e). The product was obtained as a brown
1
solid (2.43 g, 81%); mp 171–173 ◦C; Rf (CHCl3/EtOAc, 5:1 v/v) 0.27. H-NMR (400 MHz, DMSO-d6):
δ
1.33 (s, 9H, C(CH3)3), 6.74 (d, 2H, J = 8.4 Hz, 2-Ar: H-3, H-5), 7.10 (s, 2H, NH2), 7.58 (d, 2H, J = 8.8 Hz
5-Ar: H-30, H-50), 7.76 (d, 2H, J = 8.4 Hz, 2-Ar: H-2, H-6), 7.96 (d, 2H, J = 8.8 Hz, 5-Ar: H-20, H-60);
13C-NMR (100 MHz, DMSO-d6):
30.8, 34.8, 114.1, 126.2, 127.3, 127.4, 130.2, 142.3, 154.5, 156.5, 165.7,
179.9. IR (ATR)
: 3325, 1621, 1507 cm−1; HRMS calcd for (C18H19N5S+H+): 338.1440; found: 338.1438;
,
δ
ν
Anal. Calcd for C18H19N5S: C, 64.07; H, 5.68; N, 20.75. Found: C, 64.21; H, 5.70; N, 20.71.
3.2.4. General procedure for the synthesis of
2-[4-(N,N-dimethylamino)phenylazo]-5-phenyl-1,3,4-thiadiazole derivatives (5a–e)
Sodium nitrite (1.31 g, 0.019 mol) was introduced portion wise into concentrated sulfuric
◦
acid (20 mL). The solution was heated to 50◦ C in a water bath until complete dissolution and
then rapidly cooled in an ice/salt bath to 0 C. In the meantime, a solution of the appropriate
2-amino-5-aryl-1,3,4-thiadiazole 3a–e (0.015 mol) in glacial acetic acid (30 mL) and propionic acid
(15 mL) was prepared and added dropwise to an agitated solution of sodium nitrite in concentrated
sulfuric acid at 0–5 ◦C. Then, the mixture was stirred for 24 h and excess nitrous acid was decomposed
by the addition of urea. The resulting diazonium salt solution was slowly introduced into the mixture of
N,N-dimethylaniline (1.90 mL, 1.82 g, 0.015 mol) in 15 mL of water at 0–5 ◦C. The colored mixture was
stirred at room temperature for the next 24 h and finally neutralized with saturated sodium carbonate
solution (75 mL). The solid was filtered off, washed twice with hot water (2
The crude product (5a ) was purified by column chromatography on silica gel (CHCl3/EtOAc, 5:1 v/v).
2-[4-(N,N-Dimethylamino)phenylazo]-5-phenyl-1,3,4-thiadiazole (5a). The product was obtained as a
×
25 mL) and dried in air.
–
e
brown solid (3.20 g, 69%); mp 194–195 ◦C (191 ◦C [26]); Rf (CHCl3/EtOAc, 5:1 v/v) 0.32. IR (ATR)
ν: 1603,
1525 cm−1; Anal. Calcd for C16H15N5S: C, 62.11; H, 4.89; N, 22.64. Found: C, 62.08; H, 4.86; N, 22.67.
2-[4-(N,N-Dimethylamino)phenylazo]-5-(4-methoxyphenyl)-1,3,4-thiadiazole (5b). The product was
1
obtained as a dark red solid (3.00 g, 59%); mp 219–221 ◦C; Rf (CHCl3/EtOAc, 5:1 v/v) 0.27. H-NMR
(400 MHz, DMSO-d6):
H-5), 7.12 (d, 2H, J = 8.8 Hz, 5-Ar: H-30, H-50), 7.85 (d, 2H, J = 9.2 Hz, 2-Ar: H-2, H-6), 7.99 (d, 2H,
J = 8.8 Hz, 5-Ar: H-20, H-60); 13C-NMR (100 MHz, DMSO-d6):
40.2, 55.5, 112.2, 114.8, 122.5, 126.0,
129.2, 129.4, 142.0, 154.6, 164.8, 179.4. IR (ATR)
: 1603, 1516 cm−1; HRMS calcd for (C17H17N5SO+H+):
δ 3.17 (s, 6H, N(CH3)2), 3.86 (s, 3H, OCH3), 6.92 (d, 2H, J = 9.2 Hz, 2-Ar: H-3,
δ
ν